| Original language | American English |
|---|---|
| Journal | Journal of Clinical Oncology |
| State | Published - 2015 |
Disciplines
- Medicine and Health Sciences
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Randomized Phase II Study Comparing the MET Inhibitor Cabozantinib to Temozolomide (TMZ) or Dacarbazine (DTIC) in Ocular Melanoma: A091201.
- Bruno Bastos
Research output: Contribution to journal › Article › peer-review